CVS Pharmacy issues flu shot reminder
As National Influenza Vaccination Week runs through Saturday, CVS Pharmacy is reminding families across the U.S. that it is not too late to get their flu shots. Read More »
Rite Aid offers $5 discount on flu shots
Rite Aid has announced that their customers will be able to save $5 on flu shots during National Influenza Vaccination Week in support of the cause. Read More »
Otsuka ABILIFY MAINENA sNDA under review by FDA
Otsuka Pharmaceuticals and Lundbeck's supplemental New Drug Application for the expanded labeling of ABILIFY MAINENA has been completed and will receive a substantive review by the U.S. Food and Drug Administration. Read More »
AJHP launches redesigned website
The American Journal of Health-System Pharmacy has launched its redesigned website, AJHP.org. Read More »
ASHP accepting applications for Executive Residency program
The American Society of Health System Pharmacists is accepting applications for its 2017 ASHP Executive Residency in Association Leadership and Management. Read More »
CVS holds Black Friday sales event for ExtraCare members
CVS Pharmacy's Black Friday sales event will give its ExtraCare members the opportunity to save. Read More »
FDA approves Gilead’s Vemlidy
Vemlidy, Gilead Sciences’s treatment for chronic hepatitis B virus with compensated liver disease, has been approved by the U,S. Food and Drug Administration. Read More »
Supernus reports positive topline results for SPN-182 clinical trial
Supernus Pharmaceuticals' Phase IIb clinical trial involving SPN-812 to determine dosing ranges has turned in positive topline results for the treatment of attention deficit hyperactivity disorder (ADHD) in children. Read More »
Preferred pharmacy plans rally in comeback
Recent data from the Baltimore, Maryland-based Centers for Medicare & Medicaid Services (CMS) suggests that over eight out of ten Medicare Part D regional prescription drug plans (PDP) will utilize preferred network plans in 2017. Read More »
FDA gives fast-track approval for Medtronic’s MiniMed 670G
The U.S. Food and Drug Administration has given its approval of the MiniMed 670G hybrid closed looped system, designed to automatically monitor glucose and give suitable dose to individuals 14 years of age and older. Read More »
FDA approves update to Rexulti label
H. Lundbeck and Otsuka Pharmaceutical Development & Commercialization have reported that the U.S. Food and Drug Administration has approved the update to the Rexulti label. Read More »
ASHP partners with ISMP to develop Medication Safety Certificate Program
The American Society of Health-System Pharmacists (ASHP) has announced a collaboration with the Institute for Safe Medication Practices (ISMP) for the development of a Medication Safety Certificate Program that will begin in the spring of next year. Read More »
FDA grants tentative approval to Supernus sNDA for Trokendi XR
.jpg)
Supernus Pharmaceuticals Inc. recently reported that its Supplemental New Drug Application (sNDA) that requested an expansion to the label of Trokendi XR to include prophylaxis for migraine headaches in adults has been granted tentative approval by the U.S. Food and Drug Administration (FDA). Read More »
Medicare Part D premiums to see only slight rise in 2017
WASHINGTON, D.C. -- Medicare Part D premiums will see only a modest rise in 2017, despite costs to taxpayers growing faster than parts A and B, the Centers for Medicare and Medicaid Services (CMS) recently said in a statement. Read More »
DigiTx Partners spinoff born of alliance with Astellas Pharma, MPM Capital
DigiTx Partners, a digital health investment firm, recently resulted from a three-way partnership between San Francisco’s DigiTx Partners LLC , Tokyo-based Astellas Pharma Inc. and Boston-based MPM Capital Inc. Read More »
NCPA spawns Innovation Center for local pharmacies
To expedite and encourage the growth of independent local pharmacies in an evolving health care atmosphere, the Alexandria, Virginia-based National Community Pharmacists Association (NCPA) recently launched a new Innovation Center designed for outreach and education. Read More »
Medicare premium to stay stable
With only the slightest of increases, Medicare recently announced that the average monthly cost for a Medicare Part D prescription drug plan in 2017 is projected to remain reasonably stable at approximately $34. Read More »
Arizona Oncology championing SpaceOar hydrogel
Arizona Oncology is championing SpaceOar hydrogel, a new tool that has proven to protect patients with prostate cancer from the adverse effects of radiation therapy. Read More »
Biosimilars bear out need for FDA’s clarification
Two high-cost arthritis medications — one the world’s best-selling drug — may soon make way for generic equivalents following preliminary committee approval, but the Food and Drug Administration must still decide whether the products are fully interchangeable. Read More »
Differin Gel approved for over-the-counter sales
FDA approves Differin Gel as an over-the-counter medication; prescription no longer needed. Read More »
Alerts Sign-up